Answers are grounded in this paper and cite their sources.
The main objective of this cross-sectional investigation was to assess biomarkers associated with liver fibrosis, namely Tissue inhibitor of metalloproteinase 1 TIMP-1, Glutamate-pyruvic transaminase GPT, glutamic-oxaloacetic transaminase GOT, and Alkaline phosphatase ALP. which conduct in Tikrit University, College of Science /Biology Department the study samples collected from patients in Dialysis Unit in Tikrit Teaching Hospital, ninty subjects where sub-divided to 60 patients of age (20– 68) years, the Ages of Patients Chronic hepatitis B Ranged From (20-67) years( 19 males and 11 females ) And The Ages Of Patients with chronic hepatitis B suffered of chronic kidney diseases (24-68) Years ( 18males and 12 females) and 30 as control group aged (20-67) years, in this investigation Enzyme linked immunosorbent assay (ELISA) kites were employed to assess serum concentrations of (TIMP-1), Whereas used Monarch-240 to detect the activity of enzymes such as GPT, GOT and ALP. The findings of the present investigation demonstrated in chronic hepatitis patients there were significant increased (P≤0.05) in the levels of TIMP-1, and activity of GPT and ALP whereas no significant rise (P≥0.05) for activity of GOT when compared with control. In patients with chronic hepatitis B (CHB) suffered of chronic kidney diseases(CKD) there were significant raised (P<0.05) in the levelsTIMP-1, ALT and ALP while no significant rised (P≥0.05) in levels of AST when compared with control. Current data suggest that TIMP-1 can be a promising biomarker of active fibrogenesis, after HBV chronic infection.
No takes yet. Share an insight, caveat, or question.
Iman Ahmed Abdulla (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: